Skip to main content
Clinical Trials/NCT01307748
NCT01307748CompletedPhase 2

Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults

Oregon Health and Science University1 site in 1 country92 target enrollmentStarted: December 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
92
Locations
1
Primary Endpoint
Percent of Baseline Level of Salivary Cortisol

Study Overview

Brief Summary

The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works.

Detailed Description

The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works by comparing participants' physiologic responses to laboratory challenge tasks with and without experiencing aromatherapy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •in good physical and cognitive health
  • •reporting moderate level of stress
  • •able to perceive aromas
  • •able to understand and follow study instructions

Exclusion Criteria

  • •taking medications affecting central nervous system (CNS) function or physiologic measures (e.g. steroids or neuroleptics)
  • •reporting smell sensitivities or allergies
  • •smoking presently or in the past less than one year prior to enrollment

Arms & Interventions

stress reducing aroma

Experimental

aroma with reported stress reducing effects

Intervention: aroma (Other)

Placebo aroma 1

Placebo Comparator

Intervention: aroma (Other)

Placebo aroma 2

Placebo Comparator

Intervention: aroma (Other)

Outcomes

Primary Outcomes

Percent of Baseline Level of Salivary Cortisol

Time Frame: assessed at baseline (60 min prior to aroma exposure and stress), stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery)

Percent of baseline level of salivary cortisol (values greater than baseline indicate increased stress)

Secondary Outcomes

  • Cognitive Performance: Percent Change From Baseline in Digit Span Backward Task Score(Baseline (60 min prior to aroma exposure and stress), post-stress (60 min after completing stress battery))
  • Electroencephalography (EEG) Frontal Asymmetry(assessed at baseline (60 min prior to aroma exposure and stress), at the onset of aromatherapy exposure, stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Barry S. Oken

Professor

Oregon Health and Science University

Study Sites (1)

Loading locations...

Similar Trials